ePlex Instrument
Instrumentation For Clinical Multiplex Test Systems. 510(k) K163652, from Genmark Diagnostics, Incorporated (Carlsbad, CA). Product code NSU, class 2.
As of Nov 20, 2026, K163652 is an FDA 510(k) held by Genmark Diagnostics, Incorporated, substantially equivalent on Jun 9, 2017 after 168 days, with no recalls tied to it in FDA's recall database.
- Review time: 168 days
- Recalls: 0
The ePlex Instrument is an automated in vitro diagnostic (IVD) device designed to perform multiplexed nucleic acid tests for the simultaneous detection and identification of nucleic acid targets by processing single-use cartridges developed and manufactured by GenMark Diagnostics, Inc.
- Esensor Warfarin Sensitivity and XT-8 InstrumentK073720 · Osmetech Molecular Diagnostics · Jul 17, 2008
- Esensor CF Genotyping Testm Esensor System, Esensor Cystic Fibrosis Genotyping Test, Esensor Instrument, Models XT-8K090901 · Osmetech Molecular Diagnostics · Jul 6, 2009
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 23, 2016
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.2570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files